Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 19.8.2021XANTIS PHARMA LIMITED (XNT-1)89417Meloxikam Xantis 15 mg (tbl 20x15 mg (blis.OPA/Al/PVC/Al))17.8.2021O
 19.8.2021sanofi-aventis groupe (SOI-1)25131CLEXANE 4000 IU (40 mg)/0,4 ml (sol inj 10x0,4 ml/40 mg (striek.inj.napl.skl.) s bezp.systémom (E))16.8.2021O
 18.8.2021Opella Healthcare Slovakia s.r.o. (OPL)56035Ibalgin 600 (tbl flm 30x600 mg (blis. PVC/Al))12.8.2021O
 18.8.2021Janssen - Cilag International N.V. (JNS)7422DCOVID-19 Vaccine Janssen injekčná suspenzia (sus inj 20x2,5 ml (liek.inj.skl.))15.7.2021Z
 17.8.2021Roche Registration GmbH (HLR-DE)7903CRoActemra 162 mg injekčný roztok v naplnenom pere (sol ira 4x0,9 ml/162 mg (striek.inj.napl.skl. v pere))17.8.2021O
 17.8.2021KRKA, d.d., Novo mesto (KRK-2)3210BOprymea 3,15 mg tablety s predĺženým uvoľňovaním (tbl plg 30x3,15 mg (blis.OPA/Al/vysušovadlo/PE/Al))16.8.2021O
 17.8.2021KRKA, d.d., Novo mesto (KRK-2)5037CFlebaven 1 000 mg tablety (tbl 90x1000 mg (blis.PVC/PVDC/Al))16.8.2021O
 16.8.2021ratiopharm GmbH (RAT)38786Trandolapril-ratiopharm 2 mg (cps dur 98x2 mg)16.8.2021R
 16.8.2021ratiopharm GmbH (RAT)69884Indapamid ratiopharm 1,5 mg (tbl plg 30x1,5 mg (blister PVC/PVDc/Al))20.8.2021O
 16.8.2021Teva B.V. (TEV-NL-4)84800Irbesartan/Hydrochlorothiazid Teva 300 mg/12,5 mg filmom obalené tablety (tbl flm 28x300 mg/12,5 mg (blis.PVC/PVDC/Al))20.8.2021O
 16.8.2021Merck Europe B.V. (MCK-NL)10378Ovitrelle 250 mikrogramov injekčný roztok v naplnenom pere (sol ira 1x0,5 ml/250 µg (pero napl. + 2 x inj.ihla))16.8.2021O
 16.8.2021medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)40197BCG-medac (plv suf 1x1 set (1xliek.inj.skl.+1x50 ml vehikulum+adapt.Luer-Lock))16.8.2021R
 16.8.2021medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)87494Doxorubicin medac 2 mg/ml infúzny roztok (sol inf 1x25 ml/50 mg (liek.skl.))16.8.2021R
 13.8.2021Zentiva, k.s. (ZNT-1)01940OXAZEPAM LÉČIVA (tbl 20x10 mg (blis. PVC/Al))16.8.2021R
 13.8.2021AS KALCEKS (AKA)2199DMidazolam Kalceks 5 mg/ml injekčný/infúzny roztok (sol ijf 10x10 ml ml (amp.skl.))13.8.2021O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)